chr1-229431506-C-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PS2PP4_ModeratePP2PP3PM2_SupportingPS4_Supporting
This summary comes from the ClinGen Evidence Repository: The variant NM_001100.4:c.1127G>C in ACTA1 is a missense variant predicted to cause substitution of cysteine by serine at amino acid 376 (p.Cys376Ser) in exon 7/7. The variant is absent from gnomAD v2.1.1 with adequate coverage (PM2_Supporting). The REVEL computational prediction analysis tool gives a score of 0.946, which is above the threshold necessary to apply PP3. In addition, ACTA1, in which the variant was identified, is defined by the ClinGen Congenital Myopathies VCEP as a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease (PP2). The Z-score in gnomAD v2.1.1 is 4.53 which is above the threshold necessary to apply PP2. This variant has been reported in two probands with congenital nemaline myopathy (PS4_Supporting, PP4_Moderate PMID:25890230,19562689), and as a de novo observation with confirmed parental relationships in one of the probands (PS2, PMID:25890230). In summary, the variant meets the criteria to be classified as Pathogenic for autosomal dominant alpha-actinopathy. ACMG/AMP criteria met, as specified by the ClinGen Congenital Myopathies VCEP: PS2, PP4_Moderate, PS4_Supporting, PP2, PP3, PM2_Supporting (ClinGen Congenital Myopathies VCEP specifications version 2; 08/27/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA345144077/MONDO:0100084/147
Frequency
Consequence
NM_001100.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTA1 | NM_001100.4 | c.1127G>C | p.Cys376Ser | missense_variant | 7/7 | ENST00000366684.7 | NP_001091.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACTA1 | ENST00000366684.7 | c.1127G>C | p.Cys376Ser | missense_variant | 7/7 | 1 | NM_001100.4 | ENSP00000355645.3 | ||
ACTA1 | ENST00000366683.4 | c.1049G>C | p.Cys350Ser | missense_variant | 7/7 | 5 | ENSP00000355644.4 | |||
ACTA1 | ENST00000684723.1 | c.992G>C | p.Cys331Ser | missense_variant | 6/6 | ENSP00000508084.1 | ||||
ENSG00000290037 | ENST00000702606.1 | n.141C>G | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Alpha-actinopathy Pathogenic:1
Pathogenic, reviewed by expert panel | curation | ClinGen Congenital Myopathies Variant Curation Expert Panel, ClinGen | Aug 27, 2024 | The variant NM_001100.4:c.1127G>C in ACTA1 is a missense variant predicted to cause substitution of cysteine by serine at amino acid 376 (p.Cys376Ser) in exon 7/7. The variant is absent from gnomAD v2.1.1 with adequate coverage (PM2_Supporting). The REVEL computational prediction analysis tool gives a score of 0.946, which is above the threshold necessary to apply PP3. In addition, ACTA1, in which the variant was identified, is defined by the ClinGen Congenital Myopathies VCEP as a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease (PP2). The Z-score in gnomAD v2.1.1 is 4.53 which is above the threshold necessary to apply PP2. This variant has been reported in two probands with congenital nemaline myopathy (PS4_Supporting, PP4_Moderate PMID:25890230,19562689), and as a de novo observation with confirmed parental relationships in one of the probands (PS2, PMID:25890230). In summary, the variant meets the criteria to be classified as Pathogenic for autosomal dominant alpha-actinopathy. ACMG/AMP criteria met, as specified by the ClinGen Congenital Myopathies VCEP: PS2, PP4_Moderate, PS4_Supporting, PP2, PP3, PM2_Supporting (ClinGen Congenital Myopathies VCEP specifications version 2; 08/27/2024). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.